Iniparib (BSI-201) 化学構造
分子量: 292.03



Quality Control & MSDS


  • Compare PARP Inhibitors
  • 研究分野



情報 Iniparib (BSI-201)は、推定のPoly(ADPリボース)ポリメラーゼ(PARP I)阻害剤です
In vitro試験 BSI-201 is described as a prodrug of 4-iodo-3-nitrosobenzamide, an agent that covalently inhibits PARP1 by binding to its first zinc finger under cell-free conditions. Treatment of 120 μM BSI-201 plus buthionine sulfoximine (BSO) induces a 95% cell death among 855-2 cells, and displays a similar effect in other human cancer cells. [1] BSI-201 inhibits the growth of E-ras 20 cells, the effect of which can be augmented 4-fold when BOS is added. [2] Recently BSI-201 shows no ability to inhibit PARP enzymatic or cellular activity, but can non-selectively modify cysteine-containing proteins in tumor cells, suggesting the mechanism of action for BSI-201 is likely not via inhibition of PARP activity. [3] BSI-201 (100 μM) inhibits ionizing radiation-induced single-strand breaks (SSBs) repair in human lymphoid cell lines based on large endogenous Epstein–Barr virus (EBV) circular episomes assay, resulting in 55% repair by 2 hours, which can be reversed surprisingly by knockdown of PARP1, indicating that the mechanism of inhibition does not involve trapping PARP at SSBs. [4] BSI-201 is not able to selectively kill homologous recombination (HR)-deficient cells between BRCA2-deficient PEO1 and BRCA2-revertant PEO4, or ATM-deficient GM16666 and ATM-restored GM16667 fibroblasts. BSI-201 is cytotoxic to a variety of cell lines at concentrations above 40 μM reflecting a mechanism independent of PARP. [5]
In vivo試験

推薦された実験操作 (公開の文献だけ)

細胞アッセイ: [3]

細胞系 MDA-MB-231, and MDA-MB-436
濃度 Dissolved in DMSO, final concentrations ~10 μM
処理時間 5, and 9 days
方法 Cells are exposed to various concentrations of BSI-201 for 5, and 9 days in the presence or absence of buthionine sulfoxamide (BSO). After treatment, cell proliferation is measured by CellTiter-Glo assay.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.
Body Surface Area (m2)
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download Iniparib (BSI-201) SDF
分子量 292.03


CAS No. 160003-66-7
保管 2年-20℃
6月-80℃in DMSO
別名 NSC-746045, IND-71677
溶解度 (25°C) * In vitro DMSO 58 mg/mL (198.6 mM)
<1 mg/mL (<1 mM)
エタノール 28 mg/mL (95.88 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 4-iodo-3-nitrobenzamide


カスタマーレビュー (3)

Click to enlarge
Source Neuroscience, 2010, 171, 1256–1264. Iniparib (BSI-201) purchased from Selleck
Method Western blot
Cell Lines Wt neurons
Concentrations 25 μM
Incubation Time 24 h
Results Our results indicate that TWEAK induces NF-κB activation in neurons and that this effect is abrogated by PARP-1 inhibitor BSI-201 (Fig. E). Wt neurons were incubated with TWEAK alone or in combination with BSI-201 followed by a Western blot analysis with an antibody that detects cleaved caspase-3. We found that TWEAK induces caspase-3 cleavage and that this effect is attenuated by PARP-1 inhibitor BSI-201 (Fig. F)

Click to enlarge
Source J Exp Clin Cancer Res, 2013, 32(1), 95 . Iniparib (BSI-201) purchased from Selleck
Method flow cytometry
Cell Lines MCF7-ATMi and MCF7 cells
Concentrations 0-5 uM
Incubation Time 48 h
Results MCF7-ATMi cells are more sensitive than MCF7-ctr cells to iniparib

Click to enlarge
Source , , Nat Methods, 2013, 10(10):981-4. Iniparib (BSI-201) purchased from Selleck
Method Immunoblot analysis
Cell Lines HCT116
Concentrations 50 uM
Incubation Time 40 min
Results Immunoblot analysis of PARylation after treatment with AIniparib.The asterisk indicates a nonspecific band.

製品表彰状 (7)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related PARP 阻害剤

  • ME0328

    ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1.

  • 3-Aminobenzamide

    3-Aminobenzamide is a competitive PARP inhibitor with Ki of 1.8 μM.

  • TMP269

  • Nexturastat A

    Nexturastat A is a potent and selective HDAC inhibitor with IC50 of 5 nM, >190-fold selectivity over other HDACs.

  • Olaparib (AZD2281, Ku-0059436)

    Olaparib(AZD2281, KU0059436)は1種の選択の阻害剤 、 PARP-1 と PARP-2 に作用する時、IC50 がそれぞれ 5 nM と 1 nMになる。

    Features:A potent PARP inhibitor (currently in late stage clinical trials).

  • Veliparib (ABT-888)

    Veliparib (ABT-888)は、PARP1PARP2の強力な阻害剤で、Kiがそれぞれ 5.2 nM と 2.9 nMになる。

    Features:Increases the efficacy of common cancer therapies such as radiation and alkylating agents.

  • Talazoparib (BMN 673)

    Talazoparib (BMN 673)は、新しい PARP 阻害剤で、IC50 が 0.58 nMです。

    Features:Most potent and selective PARPi reported thus far.

  • Rucaparib (AG-014699,PF-01367338)

    Rucaparib (AG-014699,PF-01367338)はPARPを抑制、Ki値が1.4 nMです。

    Features:The first PARP inhibitor used in clinical trials combined with temozolomide.

  • PJ34

    PJ34 is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.

  • AG-14361

    AG-14361は有効純化全長人PARP-1阻害剤、Ki <5nM。

    Features:The 1st high-potency PARP-1 inhibitor with the specificity & in vivo activity to enhance chemotherapy and radiation therapy of human cancers.


Tags: Iniparib (BSI-201)を買う | Iniparib (BSI-201)供給者 | Iniparib (BSI-201)を購入する | Iniparib (BSI-201)費用 | Iniparib (BSI-201)生産者 | オーダーIniparib (BSI-201) | Iniparib (BSI-201)代理店